Event on
Cardiovascular risk assessment and prevention: where do we stand?
Background
Cardiac biomarkers and lipids might play a major role in the prevention of cardiovascular diseases.
Join this session to learn from experts in cardiovascular disease prevention about the recent evidence on risk stratification, to get insights from their daily clinical practice and to learn how to use cardiac biomarkers and lipid profile in a more efficient way.
演示文稿
-
-
Naveed Sattar
(Glasgow, UK)
SpeakerThe role of troponins in primary prevention of CV events: Case report
-
Torbjørn Omland
(Oslo, NO)
SpeakerPractical recommendations for the management of patients with CV disease by using hsTnI
-
Gottfried Rudofsky
(Olten, CH)
SpeakerThe confirmed role of LDL-cholesterol for the prevention and management of cardiovascular disease in patients with diabetes
-
所提出的观点和意见仅代表作者。 此网络广播中包含的内容仅供参考/教育目的。
© 2023 Abbott. All rights reserved. All trademarks referenced are trademarks of either the Abbott group of companies or their respective owners. Any photos displayed are for illustrative purposes only. Any person depicted in such photos is a model. Products available in select markets only. COL-00000
